WAT-selective knockdown of Aldh1a1 by antisense oligonucleotides conferred a similar thermogenic program as in Aldh1a1−/− mice, prevented diet-induced weight gain and improved glucose metabolism in mice suggesting that targeting Aldh1a1 in fat could be a potential therapeutic approach counteracting metabolic disease. Here, ALDH1A1 is linked to metabolic disease.